566 results match your criteria: "Hospital Universitari Parc Tauli.[Affiliation]"
Ann Rheum Dis
December 2023
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Clin Transl Oncol
April 2024
Medical Affairs Department, MSD Spain, C/Josefa Valcarcel, 38, 28027, Madrid, Spain.
Purpose: Clinical practice guidelines recommend that all patients with metastatic colorectal cancer (mCRC) should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H). We aimed to describe the dMMR/MSI-H testing practice in patients with mCRC in Spanish centers.
Methods: Multicenter, observational retrospective study that included patients newly diagnosed with mCRC or who progressed to a metastatic stage from early/localized stages.
Biomedicines
August 2023
Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Catalonia, Spain.
Antiphospholipid antibodies (APLA) are strongly associated with thrombosis seen in patients with antiphospholipid syndrome. In COVID-19, thrombosis has been observed as one of the main comorbidities. In patients hospitalised for COVID-19, we want to check whether APLA positivity is associated with COVID-19-related thrombosis, inflammation, severity of disease, or long COVID-19.
View Article and Find Full Text PDFPediatr Allergy Immunol
August 2023
Department of Paediatrics and Child Health, University College Cork, Cork, Ireland.
Background: Anaphylaxis is rising in prevalence among children. The current recommendations on the effective transition of anaphylaxis management to adolescents and young adults suggest preparation for the transition may be considered at 11-13 years of age in accordance with the patient's developmental stage. However, there has been limited research conducted on the perspective of caregivers regarding the transition of anaphylaxis management to their children.
View Article and Find Full Text PDFActas Urol Esp (Engl Ed)
April 2024
Servicio de Urología, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain.
Introduction: The management of patients with prostate cancer (PCa) is established in clinical practice guidelines, which are based on randomized studies according to the level of evidence. In Spain, the degree of compliance with these guidelines in clinical practice is unknown.
Objectives: To describe the profiles of PCa patients at the time of diagnosis and the management of patients with localized PCa and those with BCR in Spain.
Int J Antimicrob Agents
November 2023
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas CIBERINFEC, Instituto Carlos III, Madrid, Spain; Infectious Diseases Service, Hospital del Mar; Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Background: Guidelines recommend 5-7 days of antibiotic treatment in patients with surgical infection and adequate source control. This nationwide stewardship intervention aimed to reduce the duration of treatments in surgical patients to <7 days.
Methods: Prospective cohort study evaluating surgical patients receiving antibiotics ≥7 days in 32 hospitals.
Clin Transl Allergy
July 2023
Department of Paediatrics and Child Health, University College Cork, Cork, Ireland.
Clin Exp Rheumatol
October 2023
IRCCS Istituto Giannina Gaslini, UOC Reumatologia e Malattie Autoinfiammatorie, Genova, Italy.
Eur Neuropsychopharmacol
October 2023
Department of Clinical Psychology and Psychobiology, Universitat de Barcelona, Spain; Institute of Neurosciences (UBNeuro), Universitat de Barcelona, Spain. Electronic address:
Actas Dermosifiliogr
January 2024
Servicio de Dermatología, Hospital Universitari Parc Taulí, Sabadell, Barcelona, España.
Australas J Dermatol
November 2023
Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Background And Objective: The data in clinical practice regarding the effectiveness and safety of brodalumab in psoriasis are scarce, especially at scalp and palmoplantar locations. The main objective was the percentage of patients achieving absolute PASI ≤3/ ≤1/ =0 for plaque psoriasis and the percentage of patients achieving an IGA 0-1/IGA 0 for the special locations at Week 52 of treatment.
Patients And Methods: Observational retrospective multicentre study in 28 Spanish Hospitals that included adult patients with plaque psoriasis treated with brodalumab, from September 2018 until March 2021.
Diabetes Care
September 2023
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Objective: Early worsening of diabetic retinopathy (EWDR) due to the rapid decrease of blood glucose levels is a concern in diabetes treatment. The aim of the current study is to evaluate whether this is an important issue in subjects with type 2 diabetes with mild or moderate nonproliferative DR (NPDR), who represent the vast majority of subjects with DR attended in primary care.
Research Design And Methods: This is a retrospective nested case-control study of subjects with type 2 diabetes and previous mild or moderate NPDR.
Eur Cardiol
April 2023
Hospital Universitari Parc Taulí, Universitat Autònoma de Barcelona Sabadell, Spain.
Eur Cardiol
April 2023
Hospital Universitari Parc Taulí, Cardiology, Universitat Autònoma de Barcelona Sabadell, Spain.
Eur Cardiol
April 2023
Hospital Universitari Parc Taulí, Cardiology, Universitat Autònoma de Barcelona Sabadell, Spain.
Eur Cardiol
April 2023
Hospital Universitari Parc Taulí, Cardiology, Universitat Autònoma de Barcelona Sabadell, Spain.
Eur Cardiol
April 2023
Hospital Universitari Parc Taulí, Universitat Autònoma de Barcelona Sabadell, Spain.
Future Cardiol
May 2023
Internal Medicine Department, University Hospital of Getafe, 28905, Madrid, Spain.
Front Med (Lausanne)
June 2023
Intensive Care Department, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
J Clin Endocrinol Metab
November 2023
Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Centre Rotterdam, 3015 GD Rotterdam, The Netherlands.
Context: Prader-Willi syndrome (PWS) is a complex disorder combining hypothalamic dysfunction, neurodevelopmental delay, hypotonia, and hyperphagia with risk of obesity and its complications. PWS is caused by the loss of expression of the PWS critical region, a cluster of paternally expressed genes on chromosome 15q11.2-q13.
View Article and Find Full Text PDFClin Kidney J
June 2023
Inherited Kidney Diseases, Nephrology Department, Fundació Puigvert, Institut d'Investigació Biomèdica Sant Pau (IIB-SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Urol Oncol
July 2023
Department of Urology, Parc de Salut Mar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
The European Association of Urology currently recommends the use of risk-organized models to decrease the demand of prebiopsy magnetic resonance imaging (MRI) and unnecessary prostate biopsies in men with suspected prostate cancer (CaP). Low evidence suggests that men with prostate-specific antigen >10 ng/ml and an abnormal digital rectal examination (DRE) do not benefit from prebiopsy MRI and targeted biopsies. We aim to validate this low evidence in a sizable cohort and knowing how many clinically significant CaP (csCaP) would go undetected if only random biopsies were performed in these cases.
View Article and Find Full Text PDFAntibiotics (Basel)
May 2023
Infectious Diseases Department, Hospital Universitari Parc Taulí. Institut d'investigació i Innovació Parc Taulí, Universitat Autònoma de Barcelona, 08193 Sabadell, Spain.
Placenta
July 2023
Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Oncologist
October 2023
Servicio de Oncología Médica, Hospital Universitari Parc Taulí, Plaça Taulí, Sabadell, Barcelona, Spain.
Background: Patients with metastatic colorectal cancer (mCRC) and KRAS mutations have a poor prognosis, seemingly dependent on the location of the mutation. This multicenter, retrospective, cohort study assessed the frequency and prognostic value of specific KRAS mutation codon locations in mCRC patients, and survival outcomes in relation to treatment.
Materials And Methods: Data from mCRC patients treated in 10 Spanish hospitals between January 2011 and December 2015 were analyzed.